VELTASSA (Relypsa, Inc.)


Welcome to the PulseAid listing for the VELTASSA drug offered from Relypsa, Inc.. This Potassium Binder [EPC],Potassium Ion Binding Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Relypsa, Inc.
NON-PROPRIETARY NAME: patiromer
SUBSTANCE NAME: PATIROMER
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Potassium Binder [EPC],Potassium Ion Binding Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: POWDER, FOR SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-23
END MARKETING DATE: 0000-00-00


VELTASSA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVELTASSA from Relypsa, Inc.
LABELER NAME: Relypsa, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 8.4(g/1)
START MARKETING DATE: 2015-10-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53436-084_889a47fe-9cc1-49dd-b97c-63b328399eaa
PRODUCT NDC: 53436-084
APPLICATION NUMBER: NDA205739

Other PATIROMER Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Relypsa, Inc.VELTASSA